Ypsomed GmbH

Ypsomed is a leading company in the field of medical technology, specializing in the development and manufacture of injection and infusion systems for self-medication. With over 40 years of experience, Ypsomed is a renowned diabetes specialist and preferred partner of pharmaceutical and biotech companies for products such as pens, autoinjectors and pump systems[1][3].

• mylife Diabetescare: Under this brand, Ypsomed offers insulin pumps, infusion sets and other diabetes accessories directly to patients, pharmacies and hospitals[3].
• Ypsomed Delivery Systems (YDS): This division supplies injection systems and related services to pharmaceutical and biotech companies[3].
• Product portfolio: Includes autoinjectors, dual-chamber pens and pen injectors used for various clinical applications such as diabetes, infertility and growth disorders[5].

Ypsomed is committed to providing people with chronic diseases with maximum freedom and quality of life through its products and services. The company places great emphasis on open communication, supportive collaboration and a flexible, international corporate culture[2].

Although specific sustainability goals are not mentioned in the information provided, Ypsomed demonstrates a strong commitment to social responsibility through its involvement in the development of medical devices that improve the lives of people with chronic diseases.

Ypsomed offers its employees comprehensive development opportunities and a supportive working environment. The company has repeatedly been recognized as one of the best employers in Switzerland[2]. Employees appreciate the flexible work arrangements, extensive social benefits and the opportunity to develop in various career directions[2].

Ypsomed is a dynamic company characterized by innovation and technology and is constantly evolving to meet the needs of its customers.

• 1 - https://www.ypsomed.com/en/company.html
• 2 - https://www.ypsomed.com/en/careers.html
• 3 - https://www.ypsomed.com/en/media-investors/facts-figures.html
• 4 - http://i00-2.luke.ch/diplomarbeiten/book0405_72dpi.pdf
• 5 - https://www.globaldata.com/company-profile/ypsomed-holding-ag/